Related references
Note: Only part of the references are listed.Docetaxel-cisplatin might be superior to docetaxel-capecitabine in the first-line treatment of metastatic triple-negative breast cancer
Y. Fan et al.
ANNALS OF ONCOLOGY (2013)
Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era
Erin M. Olson et al.
BREAST (2013)
Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis (vol 123, pg 1402, 2013)
Pallavi Chaturvedi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience
Lorenzo Livi et al.
MEDICAL ONCOLOGY (2013)
Aspirin and cancer risk: a quantitative review to 2011
C. Bosetti et al.
ANNALS OF ONCOLOGY (2012)
Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients
Brigitte Rack et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
Kjersti Tjensvoll et al.
BMC CANCER (2012)
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
Johanna Tuomela et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer
Veronique M. Neumeister et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform
M-H Chong et al.
BRITISH JOURNAL OF CANCER (2012)
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
S. H. Sim et al.
BRITISH JOURNAL OF CANCER (2012)
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response
J. W. Thoms et al.
BRITISH JOURNAL OF CANCER (2012)
Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients
R. E. Payne et al.
BRITISH JOURNAL OF CANCER (2012)
Prognostic Value of Estrogen Receptor α and Progesterone Receptor Conversion in Distant Breast Cancer Metastases
Laurien D. C. Hoefnagel et al.
CANCER (2012)
Estrogen Promotes ER-Negative Tumor Growth and Angiogenesis through Mobilization of Bone Marrow-Derived Monocytes
Vandana Iyer et al.
CANCER RESEARCH (2012)
Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
Ugo De Giorgi et al.
CLINICAL BREAST CANCER (2012)
Prognostic Value of Circulating Tumor Cells According to Immunohistochemically Defined Molecular Subtypes in Advanced Breast Cancer
Elisabetta Munzone et al.
CLINICAL BREAST CANCER (2012)
Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Liling Zhang et al.
CLINICAL CANCER RESEARCH (2012)
Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer
Rodrigo Dienstmann et al.
DRUG SAFETY (2012)
Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence
Xuehong Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Linda Sofie Lindstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer
Farbod Shojaei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Invasive lobular carcinoma predicts micrometastasis in breast cancer
Sarah M. Gainer et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
Marco Montagner et al.
NATURE (2012)
Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor
Robyn Macfarlane et al.
ONCOLOGIST (2012)
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Ashley A. Powell et al.
PLOS ONE (2012)
Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
Wen-Hung Kuo et al.
PLOS ONE (2012)
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
Balaji Krishnamachary et al.
PLOS ONE (2012)
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
Luana Schito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
New insights into the mechanisms of organ-specific breast cancer metastasis
Girieca Lorusso et al.
SEMINARS IN CANCER BIOLOGY (2012)
Molecular networks that regulate cancer metastasis
Daniela Spano et al.
SEMINARS IN CANCER BIOLOGY (2012)
Identification of Luminal Breast Cancers That Establish a Tumor-Supportive Macroenvironment Defined by Proangiogenic Platelets and Bone Marrow-Derived Cells
Hanna S. Kuznetsov et al.
CANCER DISCOVERY (2012)
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
Randi R. Mathiesen et al.
BREAST CANCER RESEARCH (2012)
Prognostic impact of circulating tumor cells assessed with the CellSearch System (TM) and AdnaTest Breast (TM) in metastatic breast cancer patients: the DETECT study
Volkmar Mueller et al.
BREAST CANCER RESEARCH (2012)
Breast cancer statistics, 2011
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: A retrospective clinical study
P. Sanpaolo et al.
EJSO (2011)
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
Moshe Elkabets et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?
Katrien De Bock et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Quantitative High-Resolution Genomic Analysis of Single Cancer Cells
Juliane Hannemann et al.
PLOS ONE (2011)
Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast
Romano Demicheli et al.
BMC CANCER (2010)
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
Jorma J. de Ronde et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Detection of Minimal Residual Disease in Blood and Bone Marrow in Early Stage Breast Cancer
Savitri Krishnamurthy et al.
CANCER (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The granulin gene family: from cancer to dementia
Andrew Bateman et al.
BIOESSAYS (2009)
Tumor dormancy due to failure of angiogenesis: role of the microenvironment
George N. Naumov et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Systemic spread is an early step in breast cancer
Yves Huesemann et al.
CANCER CELL (2008)
Systemic endocrine instigation of indolent tumor growth requires osteopontin
Sandra S. McAllister et al.
CELL (2008)
Evolution of Bevacizumab-Based Therapy in the Management of Breast Cancer
Jasgit C. Sachdev et al.
CLINICAL BREAST CANCER (2008)
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Tanja Fehm et al.
BREAST CANCER RESEARCH (2008)
Recurrence dynamics does not depend on the recurrence site
Romano Demicheli et al.
BREAST CANCER RESEARCH (2008)
Osteopontin overexpression in breast cancer: Knowledge gained and possible implications for clinical management
Alan B. Tuck et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers
Piyush B. Gupta et al.
CANCER RESEARCH (2007)
Molecular mechanisms of metastasis
Dave S. B. Hoon et al.
CANCER AND METASTASIS REVIEWS (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Extending survival with chemotherapy in metastatic breast cancer
J O'Shaughnessy
ONCOLOGIST (2005)
Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma
ST Cheung et al.
CLINICAL CANCER RESEARCH (2004)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The complexities of breast cancer desmoplasia
RA Walker
BREAST CANCER RESEARCH (2001)
Hypoxia and oxidative stress in breast cancer - Hypoxia signalling pathways
CW Pugh et al.
BREAST CANCER RESEARCH (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
